Atlas Trials

Dual PD-1 and JAK2 Inhibition in Hematological Malignancies

Clinical trial NCT04016116 · WITHDRAWN

Trial details

NCT number
NCT04016116
Sponsor
NYU Langone Health
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
CancerHematological Malignancy
Start date
2019-12-01
Primary completion
2020-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.